QoR-9 AS predicTor of postopErative Complications
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03669419 |
|
Recruitment Status :
Completed
First Posted : September 13, 2018
Last Update Posted : August 25, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Postoperative Complications | Diagnostic Test: QoR 9 Questionnaire |
| Study Type : | Observational |
| Actual Enrollment : | 3854 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | QoR-9 AS predicTor of postopErative Complications |
| Actual Study Start Date : | June 20, 2017 |
| Actual Primary Completion Date : | December 6, 2019 |
| Actual Study Completion Date : | July 12, 2020 |
- Diagnostic Test: QoR 9 Questionnaire
The QoR-9 as established patient-centred outcome measure, which is validated in German language, is surveyed preoperatively, as well as on postoperative day 1 and 3 after non-cardiac surgery. Postoperative complications are evaluated using the Clavien-Dindo Score. A follow-up is intended after 6 months. Preoperative risk is estimated using the ASA (American Society of Anesthesiologists) and the POSPOM (Preoperative Score to predict postoperative mortality) score.
- Postoperative Complications evaluated by Clavien- Dindo Score [ Time Frame: Date of Surgery till Discharge from Hospital (approximately 30 days) ]Nine domains are evaluated: Pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, wound, haematological and pain. Each domain is graded between grade I and V (death of a patient).
- hospital mortality [ Time Frame: Date of Surgery till Discharge from Hospital (approximately 30 days) ]Rate of Mortality among study patients
- 6-month mortality [ Time Frame: 6 month after date of surgery ]Mortality among patients 6 months after surgery
- Superiority of QoR-9 questionnaire against common Outcome Score [ Time Frame: Date of surgery until 6 month follow-up ]Comparison of different risk estimates and Outcome Scores
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
3854 patients undergoing surgery at Klinikum Rechts der Isar, Technical University who have good knowledge of German Language.
Surgical procedures include all departments except cardiac surgery.
Inclusion Criteria:
- written informed consent
- undergoing non-cardiac surgery
- good knowledge of German language
Exclusion Criteria:
- blind
- out-patient
- pregnant
- psychiatric disturbance that preclude cooperation
- decline to participate
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03669419
| Germany | |
| Klinikum Rechts der Isar, Technische Universität München | |
| München, Bavaria, Germany, 81675 | |
| Study Director: | Bettina Jungwirth, Prof. | Department of Anesthesia, Klinikum rechts der Isar, TU Munich |
| Responsible Party: | Technische Universität München |
| ClinicalTrials.gov Identifier: | NCT03669419 |
| Other Study ID Numbers: |
QoR- ASPECT |
| First Posted: | September 13, 2018 Key Record Dates |
| Last Update Posted: | August 25, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Outcome Postoperative Complications Failure to rescue QoR-9 patient-centred questionnaire |
|
Postoperative Complications Pathologic Processes |

